Sagasser law firm advises Linbox on its first fund raising.
Étienne Épron, managing partner of Sagasser and Oscar Lefeuvre, associate, had the pleasure of advising LinBox SAS on a €2.3 million fundraising campaign, with more than €1 million in equity/quasi equity and 1.3 million in bank financing.
LinBox SAS is the first French company capable of offering to operators in the medical sector the services of a bio-bank using liquid and gaseous nitrogen storage technology, thus enabling them to outsource their needs for cryopreservation solutions of human products for scientific and therapeutic purposes.
This operation involved German and French manufacturers operating within the sector as well as several private investors.
Thanks to this financing, LinBox shall be able to offer its cryopreservation services from the first quarter of 2021 at a high security site located in Seine-et-Marne in the Val d’Europe Agglomeration (France).
This highly regulated activity will be supervised by the ANSM (the French National Agency for the safety of Medicines and Health Products) in full compliance with French and European regulations applicable to cell therapy and research.
This service will complement the advisory, audit and training activities for cell therapy centres, biotechnology companies and pharmaceutical groups, in optimising and securing their internal cryopreservation facilities.
Sagasser is an international business and tax law firm operating in Franco-German and Franco-Russian environments. Sagasser regularly advises bio-tech and medtech players in structuring and fund-raising operations.